Fundraising FoxEilean Therapeutics
1 known investors
Find your way into Eilean Therapeutics
Each arrow is one introduction. Sign up to fill in the first one.
821 people can intro you to Iain
Ask Roger Ulrich to introduce you to Iain Dukes
You →Roger · together at Kartosthera →Iain
Sign up to find every way you can get introduced to Eilean Therapeutics
- Your email: who you already know at Eilean Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Eilean Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Eilean Therapeutics is a small molecule oncology drug discovery company developing pan-variant therapies that target resistance mechanisms in hematologic malignancies. Founded in 2022, it focuses on creating first- and best-in-class treatments for blood cancers that have developed resistance to existing therapies.
Founders & leadership
ID
JB
John ByrdInterim Chief Medical Officer
NS
Nikolay SavchukCOO
AB
Amy BurdCSO
BL
Brian LedwithChief Development Officer
FP
Fraser PickersgillHead CMC
Investors · 1
OrbiMedlisted by OrbiMedNew York · $1M – $75M
How we know: OrbiMed's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Eilean Therapeutics do?
- Eilean Therapeutics is a small molecule oncology drug discovery company developing pan-variant therapies that target resistance mechanisms in hematologic malignancies. Founded in 2022, it focuses on creating first- and best-in-class treatments for blood cancers that have developed resistance to existing therapies.
- Who founded Eilean Therapeutics?
- Eilean Therapeutics was founded by Iain Dukes, John Byrd.
- Who are Eilean Therapeutics's investors?
- Eilean Therapeutics's investors include OrbiMed.